迈瑞CL-1200i高敏肌钙蛋白I免疫分析法的分析性能评估
本研究评估了迈瑞CL-1200i化学发光高敏肌钙蛋白I(hs-cTnI)免疫分析法的分析性能,包括空白限、检测限、功能灵敏度、不精密度、线性、99百分位参考上限及与已验证方法的 concordance。结果显示LOB 0.32 ng/L、LOD 0.35 ng/L,功能灵敏度0.35 ng/L,线性r=1.00(0.8-9726.9 ng/mL),批内、批间和总不精密度分别为1.1-1.3%、5.5-8.1%和5.6-8.2%。246名健康献血者99百分位URL为9.2 ng/L(女4.3 ng/L,男12.3 ng/L),与Access hs-TnI的Spearman相关系数0.97,平均偏差7.2%(95%CI 2.6-11.9%)。结论认为整体性能与其他市售hs-cTnI方法相当,可作为替代方法。
要点
- LOB 0.32 ng/L,LOD 0.35 ng/L,功能灵敏度0.35 ng/L(不精密度<10%)。
- 99百分位URL为9.2 ng/L(女4.3 ng/L,男12.3 ng/L),基于246名健康献血者残余血浆。
- 与Access hs-TnI相关性好(r=0.97),平均偏差7.2%(95%CI 2.6-11.9%)。
核心结论
- 迈瑞CL-1200i hs-cTnI免疫分析法的整体分析性能与其他市售hs-cTnI方法相当,可作为可行的替代方法。
研究设计与样本
- 评估迈瑞CL-1200i化学发光hs-cTnI免疫分析法的分析性能,包括LOB、LOD、功能灵敏度、不精密度、线性、99百分位URL及与另一已验证hs-cTnI化学发光法的 concordance。
主要发现
- LOB为0.32 ng/L,LOD为0.35 ng/L,功能灵敏度为0.35 ng/L。
- 线性范围0.8-9726.9 ng/mL内r=1.00,批内、批间和总不精密度分别为1.1-1.3%、5.5-8.1%和5.6-8.2%。
- 246名健康献血者残余血浆的99百分位URL为9.2 ng/L(女4.3 ng/L,男12.3 ng/L)。
- 与Access hs-TnI的Spearman相关系数0.97,平均偏差7.2%(95%CI 2.6-11.9%)。
关键数值与推荐
- LOB 0.32 ng/L,LOD 0.35 ng/L,功能灵敏度0.35 ng/L(cTnI值不精密度<10%)。
- 99百分位URL 9.2 ng/L(女性4.3 ng/L,男性12.3 ng/L),基于246名健康献血者残余血浆。
- 线性r=1.00(0.8-9726.9 ng/mL),批内不精密度1.1-1.3%,批间5.5-8.1%,总5.6-8.2%。
- 与Access hs-TnI Spearman相关系数0.97,平均偏差7.2%(95%CI 2.6-11.9%)。
临床怎么用
- 该hs-cTnI方法分析性能与其他市售方法相当,可用于临床常规检测。
- 性别特异性99百分位URL(女4.3 ng/L,男12.3 ng/L)可用于临床解读。
局限性
- 未能证实该方法先前报道的非常乐观的分析特性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The current study was designed to evaluate the analytical performance of the new Mindray highly sensitive cardiac troponin I (hs-cTnI) chemiluminescent immunoassay on Mindray CL-1200i, as a thorough validation of novel hs-cTnI methods is required before introduction into clinical practice. METHODS: The evaluation of the analytical performance of this hs-cTnI immunoassay encompassed the calculation of the limit of blank (LOB), limit of detection (LOD), functional sensitivity, imprecision, linearity, 99th percentile upper reference limit (URL) and concordance with another previously validated hs-cTnI chemiluminescent immunoassay. RESULTS: The LOB and LOD were 0.32 and 0.35 ng/L, whilst the functional sensitivity (expressed as cTnI value with <10 % imprecision), was 0.35 ng/L. The linearity was excellent throughout a wide range of clinically measurable values (r=1.00 between 0.8 and 9,726.9 ng/mL). The intra-assay, inter-assay and total imprecision were 1.1-1.3 %, 5.5-8.1 % and 5.6-8.2 %, respectively. The 99th percentile URL calculated using residual plasma from 246 ostensibly healthy blood donors was 9.2 ng/L (4.3 ng/L in women vs. 12.3 ng/L in men). The Spearman's correlation between Mindray hs-cTnI and Access hs-TnI was 0.97, with mean bias of 7.2 % (95 % CI, 2.6-11.9 %). CONCLUSIONS: Although we failed to confirm the very optimistic analytical characteristics previously reported for this method, our evaluation of the novel Mindray hs-cTnI immunoassay on CL-1200i demonstrated that the overall performance is comparable to that of other commercially available hs-cTnI techniques, making it a viable alternative to other methods.
引用
- Lippi G, Pighi L, Paviati E, et al. Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i. Clin Chem Lab Med. 2024. PMID: 38176023. doi:10.1515/cclm-2023-1448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。